1.

CoMix : comparing mixing patterns in the Belgian population during and after lockdown

2.

CoMix : comparing mixing patterns in the Belgian population during and after lockdown

1.

Economic evaluation of vaccines : Belgian reflections on the need for a broader perspective

2.

Economic evaluation of vaccines : Belgian reflections on the need for a broader perspective

1.

Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories

2.

Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories

3.

Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories

4.

Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories

5.

Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories

6.

Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories

7.

Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories

8.

Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories

1.

A data-driven metapopulation model for the Belgian COVID-19 epidemic : assessing the impact of lockdown and exit strategies

2.

A data-driven metapopulation model for the Belgian COVID-19 epidemic : assessing the impact of lockdown and exit strategies

1.

Belgian population norms for the EQ-5D-5L, 2018

2.

Belgian population norms for the EQ-5D-5L, 2018

3.

Belgian population norms for the EQ-5D-5L, 2018

4.

Belgian population norms for the EQ-5D-5L, 2018

5.

Belgian population norms for the EQ-5D-5L, 2018

6.

Belgian population norms for the EQ-5D-5L, 2018

7.

Belgian population norms for the EQ-5D-5L, 2018

8.

Belgian population norms for the EQ-5D-5L, 2018

9.

Belgian population norms for the EQ-5D-5L, 2018

1.

Authors' reply to comment on "Cost-effectiveness analysis of Herpes Zoster vaccination in 50-to 85-year-old immunocompetent Belgian cohorts: a comparison between no vaccination, th...

2.

Authors' reply to comment on "Cost-effectiveness analysis of Herpes Zoster vaccination in 50-to 85-year-old immunocompetent Belgian cohorts: a comparison between no vaccination, th...

1.

Serotype 19A and 6C account for one-third of pneumococcal carriage among Belgian day-care children four years after a shift to a lower-valent PCV

2.

Serotype 19A and 6C account for one-third of pneumococcal carriage among Belgian day-care children four years after a shift to a lower-valent PCV

1.

Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018)

2.

Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018)

3.

Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018)

4.

Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018)

5.

Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018)

6.

Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018)

1.

Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective

2.

Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective

3.

Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective

4.

Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective

5.

Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective

1.

Evolutions in Both Co-Payment and Generic Market Share for Common Medication in the Belgian Reference Pricing System

1.

CoMix: comparing mixing patterns in the Belgian population during and after lockdown

2.

CoMix: comparing mixing patterns in the Belgian population during and after lockdown

3.

CoMix: comparing mixing patterns in the Belgian population during and after lockdown

4.

CoMix: comparing mixing patterns in the Belgian population during and after lockdown

5.

CoMix: comparing mixing patterns in the Belgian population during and after lockdown

1.

Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine,...

1.

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

2.

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

3.

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

4.

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

5.

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

6.

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

7.

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

8.

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

9.

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

1.

Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of aty...

2.

Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of aty...

3.

Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of aty...

4.

Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of aty...

1.

CoMix: comparing mixing patterns in the Belgian population during and after lockdown.

2.

CoMix: comparing mixing patterns in the Belgian population during and after lockdown.

3.

CoMix: comparing mixing patterns in the Belgian population during and after lockdown.

1.

Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV

2.

Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV

3.

Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV

4.

Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV

5.

Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV

1.

Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression

2.

Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression

3.

Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression

4.

Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression

5.

Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression

1.

Cost-effectiveness analysis of herpes zoster vaccination in 50-to 85-year-old immunocompetent Belgian cohorts : a comparison between no vaccination, the adjuvanted subunit vaccine,...

2.

Cost-effectiveness analysis of herpes zoster vaccination in 50-to 85-year-old immunocompetent Belgian cohorts : a comparison between no vaccination, the adjuvanted subunit vaccine,...

1.

An Economic Evaluation of Hepatitis A Vaccination in Dutch Military Personnel

1.

Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium?

2.

Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium?

3.

Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium?

1.

Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.

2.

Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.

3.

Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.

4.

Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.

5.

Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.

6.

Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.

7.

Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.

1.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

2.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

3.

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.

1.

Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium

2.

Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium

3.

Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium

1.

Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium

2.

Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium

3.

Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium

1.

Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin

1.

Childhood varicella-zoster virus vaccination in Belgium: Cost-effective only in the long run or without exogenous boosting?

1.

The direct disease burden of COVID-19 in Belgium in 2020 and 2021

2.

The direct disease burden of COVID-19 in Belgium in 2020 and 2021

3.

The direct disease burden of COVID-19 in Belgium in 2020 and 2021

4.

The direct disease burden of COVID-19 in Belgium in 2020 and 2021

5.

The direct disease burden of COVID-19 in Belgium in 2020 and 2021

1.

Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014.

1.

Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Aty...

2.

Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Aty...

3.

Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Aty...

4.

Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Aty...

5.

Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Aty...

6.

Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Aty...

1.

A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies

2.

A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies

3.

A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies

1.

Lyme borreliosis in Belgium: a cost-of-illness analysis

2.

Lyme borreliosis in Belgium: a cost-of-illness analysis

3.

Lyme borreliosis in Belgium: a cost-of-illness analysis

4.

Lyme borreliosis in Belgium: a cost-of-illness analysis

5.

Lyme borreliosis in Belgium: a cost-of-illness analysis

6.

Lyme borreliosis in Belgium: a cost-of-illness analysis

7.

Lyme borreliosis in Belgium: a cost-of-illness analysis

8.

Lyme borreliosis in Belgium: a cost-of-illness analysis

9.

Lyme borreliosis in Belgium: a cost-of-illness analysis

1.

The health and economic burden of haemophilia in Belgium : a rare, expensive and challenging disease

1.

Assessing the risk of measles resurgence in a highly vaccinated population : Belgium anno 2013

1.

Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014

1.

Costeffectiveness of screening for active cases of tuberculosis in Flanders, Belgium

2.

Costeffectiveness of screening for active cases of tuberculosis in Flanders, Belgium

3.

Costeffectiveness of screening for active cases of tuberculosis in Flanders, Belgium

1.

The HUMTICK study : protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium

1.

The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006 : a comparative analysis with hepatitis A virus seroprevalence

1.

How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018

1.

Close contact infection dynamics over time : insights from a second large-scale social contact survey in Flanders, Belgium, in 2010-2011

2.

Close contact infection dynamics over time : insights from a second large-scale social contact survey in Flanders, Belgium, in 2010-2011

3.

Close contact infection dynamics over time : insights from a second large-scale social contact survey in Flanders, Belgium, in 2010-2011

1.

COVID-19 and retail : the catalyst for e-commerce in Belgium?

1.

The health and economic impact of acute gastroenteritis in Belgium, 2010-2014

1.

Seroprevalence of IgG antibodies against SARS-CoV-2-a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020

1.

Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022

1.

Lyme borreliosis in Belgium : a cost-of-illness analysis

1.

Longitudinal social contact data analysis : insights from 2 years of data collection in Belgium during the COVID-19 pandemic

1.

Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008

1.

The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands

2.

The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands

3.

The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands

1.

Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium

1.

Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013

1.

Inferring rubella outbreak risk from seroprevalence data in Belgium